TIS 0.00% 0.0¢ tissue therapies limited

TIS Vs Avita Medical, page-4

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    I guess we'll know more about that soon. Avita have conducted a pilot trial for the use of Regenercell in treating venous leg ulcers. From today's AGM:
    Results of Randomized, Multi-Center VLU Pilot Study Expected in Q4-2015

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.